Andrew Cheng sold $1.2M of Akero Therapeutics (AKRO)

Executed Mar 10 2025, disclosed Mar 12 2025, 2 days later.

Value, as filed

$1.2M

28,784 sh × $41.75

Executed

Mar 10 2025

the trade date, as filed

Disclosed

Mar 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AC Andrew Cheng President and CEO profile →

Andrew Cheng (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AKRO. The largest single filing was $1.6M of AKRO (30,000 sh × $53.98, as filed), executed Oct 10 2025.

The name

AKRO AKRO AKRO · 63 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Cheng in AKRO

AKROSALE Akero Therapeutics, Inc. $1.6M
30,000 sh × $53.98
Exec Oct 10 2025
Filed Oct 14 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $1.3M
29,842 sh across 2 lots
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $1.4M
29,600 sh across 2 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $1.5M
30,000 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $363K
6,620 sh × $54.84
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $2.0M
37,837 sh across 3 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $1.2M
30,000 sh across 2 lots
Exec May 12 2025
Filed May 13 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $1.1M
30,000 sh × $35.23
Exec Apr 10 2025
Filed Apr 11 2025 · 5:30 PM ET